202 related articles for article (PubMed ID: 38011559)
1. Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy.
Bao Y; Qiao Y; Choi JE; Zhang Y; Mannan R; Cheng C; He T; Zheng Y; Yu J; Gondal M; Cruz G; Grove S; Cao X; Su F; Wang R; Chang Y; Kryczek I; Cieslik M; Green MD; Zou W; Chinnaiyan AM
Proc Natl Acad Sci U S A; 2023 Dec; 120(49):e2314416120. PubMed ID: 38011559
[TBL] [Abstract][Full Text] [Related]
2. Immune Checkpoint Blockade Augments Changes Within Oncolytic Virus-induced Cancer MHC-I Peptidome, Creating Novel Antitumor CD8 T Cell Reactivities.
Kim Y; Konda P; Murphy JP; Paulo JA; Gygi SP; Gujar S
Mol Cell Proteomics; 2022 Feb; 21(2):100182. PubMed ID: 34922008
[TBL] [Abstract][Full Text] [Related]
3. PIKfyve controls dendritic cell function and tumor immunity.
Choi JE; Qiao Y; Kryczek I; Yu J; Gurkan J; Bao Y; Gondal M; Tien JC; Maj T; Yazdani S; Parolia A; Xia H; Zhou J; Wei S; Grove S; Vatan L; Lin H; Li G; Zheng Y; Zhang Y; Cao X; Su F; Wang R; He T; Cieslik M; Green MD; Zou W; Chinnaiyan AM
bioRxiv; 2024 Mar; ():. PubMed ID: 38464258
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F
Front Immunol; 2019; 10():1505. PubMed ID: 31333652
[TBL] [Abstract][Full Text] [Related]
5. Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization and degradation.
Zhang B; Li J; Hua Q; Wang H; Xu G; Chen J; Zhu Y; Li R; Liang Q; Wang L; Jin M; Tang J; Lin Z; Zhao L; Zhang D; Yu D; Ren J; Zhang T
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36596591
[TBL] [Abstract][Full Text] [Related]
6. Selective autophagy of MHC-I promotes immune evasion of pancreatic cancer.
Yamamoto K; Venida A; Perera RM; Kimmelman AC
Autophagy; 2020 Aug; 16(8):1524-1525. PubMed ID: 32459143
[TBL] [Abstract][Full Text] [Related]
7. CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade.
Sato Y; Bolzenius JK; Eteleeb AM; Su X; Maher CA; Sehn JK; Arora VK
JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518683
[TBL] [Abstract][Full Text] [Related]
8. Therapy-Induced MHC I Ligands Shape Neo-Antitumor CD8 T Cell Responses during Oncolytic Virus-Based Cancer Immunotherapy.
Murphy JP; Kim Y; Clements DR; Konda P; Schuster H; Kowalewski DJ; Paulo JA; Cohen AM; Stevanovic S; Gygi SP; Gujar S
J Proteome Res; 2019 Jun; 18(6):2666-2675. PubMed ID: 31095916
[TBL] [Abstract][Full Text] [Related]
9. Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistance in SCLC.
Nguyen EM; Taniguchi H; Chan JM; Zhan YA; Chen X; Qiu J; de Stanchina E; Allaj V; Shah NS; Uddin F; Manoj P; Liu M; Cai SF; Levine R; Quintanal-Villalonga Á; Sen T; Chow A; Rudin CM
J Thorac Oncol; 2022 Aug; 17(8):1014-1031. PubMed ID: 35691495
[TBL] [Abstract][Full Text] [Related]
10. New generation of DNA-based immunotherapy induces a potent immune response and increases the survival in different tumor models.
Lopes A; Bastiancich C; Bausart M; Ligot S; Lambricht L; Vanvarenberg K; Ucakar B; Gallez B; Préat V; Vandermeulen G
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795383
[TBL] [Abstract][Full Text] [Related]
11. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I.
Yamamoto K; Venida A; Yano J; Biancur DE; Kakiuchi M; Gupta S; Sohn ASW; Mukhopadhyay S; Lin EY; Parker SJ; Banh RS; Paulo JA; Wen KW; Debnath J; Kim GE; Mancias JD; Fearon DT; Perera RM; Kimmelman AC
Nature; 2020 May; 581(7806):100-105. PubMed ID: 32376951
[TBL] [Abstract][Full Text] [Related]
12. IFN-γ treatment protocol for MHC-I
Stifter K; Krieger J; Ruths L; Gout J; Mulaw M; Lechel A; Kleger A; Seufferlein T; Wagner M; Schirmbeck R
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32868392
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy and CD40 Activation Separately Augment Immunity to Checkpoint Blockade in Cancer.
Rech AJ; Dada H; Kotzin JJ; Henao-Mejia J; Minn AJ; Twyman-Saint Victor C; Vonderheide RH
Cancer Res; 2018 Aug; 78(15):4282-4291. PubMed ID: 29844122
[TBL] [Abstract][Full Text] [Related]
14. Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade.
Gu SS; Zhang W; Wang X; Jiang P; Traugh N; Li Z; Meyer C; Stewig B; Xie Y; Bu X; Manos MP; Font-Tello A; Gjini E; Lako A; Lim K; Conway J; Tewari AK; Zeng Z; Sahu AD; Tokheim C; Weirather JL; Fu J; Zhang Y; Kroger B; Liang JH; Cejas P; Freeman GJ; Rodig S; Long HW; Gewurz BE; Hodi FS; Brown M; Liu XS
Cancer Discov; 2021 Jun; 11(6):1524-1541. PubMed ID: 33589424
[TBL] [Abstract][Full Text] [Related]
15. Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies.
Minnar CM; Chariou PL; Horn LA; Hicks KC; Palena C; Schlom J; Gameiro SR
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764364
[TBL] [Abstract][Full Text] [Related]
16. Qa-1
Zhang X; Sabio E; Krishna C; Ma X; Wang J; Jiang H; Havel JJ; Chan TA
Mol Cancer Res; 2021 Jun; 19(6):1076-1084. PubMed ID: 33674442
[TBL] [Abstract][Full Text] [Related]
17. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
Merritt RE; Yamada RE; Crystal RG; Korst RJ
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
[TBL] [Abstract][Full Text] [Related]
18. Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells.
Brea EJ; Oh CY; Manchado E; Budhu S; Gejman RS; Mo G; Mondello P; Han JE; Jarvis CA; Ulmert D; Xiang Q; Chang AY; Garippa RJ; Merghoub T; Wolchok JD; Rosen N; Lowe SW; Scheinberg DA
Cancer Immunol Res; 2016 Nov; 4(11):936-947. PubMed ID: 27680026
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance.
Deng Y; Xia X; Zhao Y; Zhao Z; Martinez C; Yin W; Yao J; Hang Q; Wu W; Zhang J; Yu Y; Xia W; Yao F; Zhao D; Sun Y; Ying H; Hung MC; Ma L
Nat Commun; 2021 Dec; 12(1):7041. PubMed ID: 34873175
[TBL] [Abstract][Full Text] [Related]
20. Autophagy Inhibition by Targeting PIKfyve Potentiates Response to Immune Checkpoint Blockade in Prostate Cancer.
Qiao Y; Choi JE; Tien JC; Simko SA; Rajendiran T; Vo JN; Delekta AD; Wang L; Xiao L; Hodge NB; Desai P; Mendoza S; Juckette K; Xu A; Soni T; Su F; Wang R; Cao X; Yu J; Kryczek I; Wang XM; Wang X; Siddiqui J; Wang Z; Bernard A; Fernandez-Salas E; Navone NM; Ellison SJ; Ding K; Eskelinen EL; Heath EI; Klionsky DJ; Zou W; Chinnaiyan AM
Nat Cancer; 2021 Sep; 2():978-993. PubMed ID: 34738088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
